BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16247467)

  • 1. Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3.
    Kumar RN; Shore SK; Dhanasekaran N
    Oncogene; 2006 Feb; 25(6):899-906. PubMed ID: 16247467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.
    Kumar RN; Ha JH; Radhakrishnan R; Dhanasekaran DN
    Mol Cell Biol; 2006 Jan; 26(1):50-62. PubMed ID: 16354679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation-specific genes activated by Galpha(12): a role for PDGFRalpha and JAK3 in Galpha(12)-mediated cell proliferation.
    Kumar RN; Radhika V; Audigé V; Rane SG; Dhanasekaran N
    Cell Biochem Biophys; 2004; 41(1):63-73. PubMed ID: 18038259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation.
    Aznar S; Valerón PF; del Rincon SV; Pérez LF; Perona R; Lacal JC
    Mol Biol Cell; 2001 Oct; 12(10):3282-94. PubMed ID: 11598209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin receptor-induced STAT3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling.
    Lo RK; Liu AM; Wise H; Wong YH
    Cell Signal; 2008 Nov; 20(11):2095-106. PubMed ID: 18755267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of Jun N-terminal kinase and p38MAP kinase by Galpha12.
    Dermott JM; Ha JH; Lee CH; Dhanasekaran N
    Oncogene; 2004 Jan; 23(1):226-32. PubMed ID: 14712227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein.
    Kashef K; Radhakrishnan R; Lee CM; Reddy EP; Dhanasekaran DN
    Neoplasia; 2011 Apr; 13(4):358-64. PubMed ID: 21472140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducer and activator of transcription 3 activation by the delta-opioid receptor via Galpha14 involves multiple intermediates.
    Lo RK; Wong YH
    Mol Pharmacol; 2004 Jun; 65(6):1427-39. PubMed ID: 15155836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
    Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.
    Vultur A; Cao J; Arulanandam R; Turkson J; Jove R; Greer P; Craig A; Elliott B; Raptis L
    Oncogene; 2004 Apr; 23(15):2600-16. PubMed ID: 15007380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of STAT3 by G alpha(s) distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase.
    Liu AM; Lo RK; Wong CS; Morris C; Wise H; Wong YH
    J Biol Chem; 2006 Nov; 281(47):35812-25. PubMed ID: 17008315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
    Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
    Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
    Wang YZ; Wharton W; Garcia R; Kraker A; Jove R; Pledger WJ
    Oncogene; 2000 Apr; 19(17):2075-85. PubMed ID: 10815799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.
    Turkson J; Bowman T; Adnane J; Zhang Y; Djeu JY; Sekharam M; Frank DA; Holzman LB; Wu J; Sebti S; Jove R
    Mol Cell Biol; 1999 Nov; 19(11):7519-28. PubMed ID: 10523640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
    Lo RK; Wong YH
    Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
    Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G2A is an oncogenic G protein-coupled receptor.
    Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ
    Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fer tyrosine kinase is important for platelet-derived growth factor-BB-induced signal transducer and activator of transcription 3 (STAT3) protein phosphorylation, colony formation in soft agar, and tumor growth in vivo.
    Lennartsson J; Ma H; Wardega P; Pelka K; Engström U; Hellberg C; Heldin CH
    J Biol Chem; 2013 May; 288(22):15736-44. PubMed ID: 23589302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome analysis of NIH3T3 cells transformed by activated Galpha12: regulation of leukemia-associated protein SET.
    Kumar RN; Radhakrishnan R; Ha JH; Dhanasekaran N
    J Proteome Res; 2004; 3(6):1177-83. PubMed ID: 15595726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.